Shari Pilon‐Thomas

6.2k citations
112 papers · 5k · 3 hit papers · h-index 35

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cytokine Signaling Pathways and Interactions
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • T-cell and B-cell Immunology
    • interferon and immune responses

Papers in

    • Cancer Immunotherapy and Biomarkers 51
    • CAR-T cell therapy research 30
    • Immunotherapy and Immune Responses 52
    • T-cell and B-cell Immunology 13
    • Immune cells in cancer 8

Shari Pilon‐Thomas

107 papers receiving 4.9k citations

Shari Pilon‐Thomas's Hit Papers

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial 2021 · 343 citations
3430+7+14Years since publication250500750

Peers

Shari Pilon‐Thomas
Comparison fields: 5 of 100
  • Oncology 2.5k
  • Immunology 1.9k
  • Cancer Research 513
  • Modeling and Simulation 112
  • Genetics 134
Replace Takuro Noguchi with:
Takuro Noguchi Japan
Cora D. Arthur United States
Roy L. Maute United States
Ángel García-Díaz Spain
Hélène Salmon United States
Jill M. Fritz United States
Matthew M. Gubin United States
Cristina Puig-Saus United States
Álvaro Teijeira Spain
Hung T. Khong United States
Shari Pilon‐Thomas relative to Takuro Noguchi Japan Takuro Noguchi's profile →
Citations per field
00.5×2×3×4.3×
Takuro Noguchi · 1×
Citations per year

Countries citing papers authored by Shari Pilon‐Thomas

Since Specialization
Citations

This map shows the geographic impact of Shari Pilon‐Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shari Pilon‐Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shari Pilon‐Thomas more than expected).

Fields of papers citing papers by Shari Pilon‐Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shari Pilon‐Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shari Pilon‐Thomas. The network helps show where Shari Pilon‐Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside Shari Pilon‐Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shari Pilon‐Thomas Line = papers co-authored together Shari Pilon‐Thomas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Hit paper breakdown →
2005882
2
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Hit paper breakdown →
2016520
3
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Hit paper breakdown →
2021343
4 2018184
5 2020179
6 2012163
7 2021146
8 2016137
9 2020134
10 2013123
11 2019122
12 2010121
13 2012103
14 201886
15 201979
16 200877
17 202375
18 201663
19 201358
20 201358

About Shari Pilon‐Thomas

Shari Pilon‐Thomas is a scholar working on Oncology, Immunology, Modeling and Simulation, Cancer Research and Infectious Diseases, having authored 112 papers that have together received 5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (52 papers), Cancer Immunotherapy and Biomarkers (51 papers), CAR-T cell therapy research (30 papers), T-cell and B-cell Immunology (13 papers), Cancer, Hypoxia, and Metabolism (8 papers), Immune cells in cancer (8 papers), Mathematical Biology Tumor Growth (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.9k citations), Cancer Research (513 citations), Modeling and Simulation (112 citations) and Genetics (134 citations). Shari Pilon‐Thomas has collaborated with scholars based in United States, China and Germany. Frequent co-authors include James J. Mulé, Amod A. Sarnaik, Krithika Nandakumar Kodumudi, Amy Mackay Weber, Robert J. Gillies, Arig Ibrahim‐Hashim, William Garrow Kerr, Marcin Kortylewski, Maciej Kujawski and Richard Jove. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, PLoS ONE, Cancer Immunology Immunotherapy, Clinical Cancer Research and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact